In this issue, Thomas et al. (2017) define the nature of accumulated ssDNA present in the neuron and astrocyte cytoplasm of TREX1 mutated stem cell--derived organoids. Accumulated ssDNAs are derived from LINE--1 endogenous retroelements, providing new clues as to the development of Aicardi--Goutières syndrome in the neural system.
unexplored. It is not clear whether cytoplasmic ssDNAs are indeed generated in TREX1 mutant cells. A likely scenario is that these ssDNAs are abortive LINE--1 retrotransposition intermediates ( Figure  1B ) that might gain access to the cytoplasm; these abortive LINE--1 intermediates might be over--produced in the absence of TREX1 activity, which normally might act to titrate the number of new LINE--1 insertions that a cell would normally accommodate. However, it is also possible that these ssDNAs are generated directly in the cytoplasm of TREX1 mutant cells, although it is not clear how these ssDNAs might be primed. Either way, it is clear that these ssDNAs generated by active LINE--1s are directly implicated in the pathophysiology of TREX1 mutant cells, and presumably of AGS patients. This data is remarkable, as it provides the first clear demonstration that active LINE--1s, and only active LINE--1s, might be directly related to human AGS pathology. In addition, these data might help clarify why mouse models of AGS do not recapitulate the major symptoms observed in human AGS patients; it is tempting to speculate that as mouse cells normally deal with an excess of active LINE--1s (approximately 3000 active LINE--1s/mouse cells), they have greater tolerance to cytoplasmic ssDNAs before eliciting an autoimmune reaction than human cells, which normally deal with just 80--100 active LINE--1s/human cell.
These results have additional important implications. For the first time, a tissue specific effect of TREX1 is observed where on the one hand, neurons become importantly affected and suffer apoptosis, something that does not occur in neural precursors or in astrocytes (Thomas, 2017) . However, and importantly, astrocytes produce type I IFN following the accumulation of LINE--1--derived ssDNA, which increased the toxic effects to which neurons were subjected.
Clinically, this study not only provides a plausible explanation for the microcephaly observed in AGS, but also provides hints as to the development of neuropsychiatric lupus. Patients with AGS caused by any of the genes with damaging mutations have increased activity of type I interferon in the cerebrospinal fluid, and patients rapidly develop neurological disabilities (Crow et al., 2015) . Although contrary to previous belief, it has now been accepted that a larger proportion of patients with SLE show neuropsychiatric manifestations. In fact, neuroimaging evidence suggests that early cases of SLE, without neurological symptomatology, suffer from glucose hypometabolism consistent with early apoptosis or atrophy in portions of the frontal and parietal cortex, as well as inflammation (Ramage et al., 2011) . It would be of interest to investigate if there is a relationship between TREX1 heterozygous mutations and the presence of apoptosis and atrophy changes early in these patients. Furthermore, in general, neuroimaging monitoring of SLE patients with TREX1 mutations may suggest the excessive production of type I IFN activity in the brain, and analysis of cerebrospinal fluid to show this, might be recommended in the clinic. TREX1 may lie behind a larger proportion of neuropsychiatric SLE (Fredi et al., 2015) patients, who in addition with AGS patients, would be good candidates for very early anti--type I IFN receptor treatment currently in clinical trials that may help them avoid critical brain damage.
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